Quality is Key
Emery Pharma’s Quality System ensures the quality, safety, and performance requirements for our Clients.
A dedicated Quality Assurance department implements all planned and systematic activities within the quality system. We produce high-quality, actionable data, to strengthen your regulatory package.
Stay in the Know
Emery Pharma scientists write about the work they have done and how they have helped companies like yours. Check out the full list of blogs here.
FDA’s Latest Nitrosamine Guidance Reinforces the need for a more Proactive Risk Management for Drug Developers and CDMOs
Alameda, California – August 3, 2026 – Emery Pharma today underscored the importance of the U.S. Food and Drug Administration’s July 24, 2026 update to its guidance on nitrosamine drug…
PK vs PD on the MSD Platform: Similar Technology, Different Bioanalytical Strategies
The Meso Scale Discovery (MSD) platform has become a cornerstone technology for both large molecule pharmacokinetic (PK) assays and pharmacodynamic (PD) biomarker assessments. Its electrochemiluminescence detection technology offers high sensitivity,…
ADA Assay Development on MSD: Practical Execution and Critical Concepts
Introduction Anti-drug antibody (ADA) assays are critical for evaluating drug safety and are required throughout pre‑clinical and clinical development. In a standard bridging ADA assay, anti-drug antibodies in the sample…